Bionovate Technologies Corp. Overview
Industry: Medical Devices
Sector: Healthcare
Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots. It intends to develop automated computerized system that treats age spots anywhere on the body. The company targets to sell its systems to physicians and spas worldwide. The company was formerly known as MJP International Ltd. and changed its name to Bionovate Technologies Corp. in December 2017. Bionovate Technologies Corp. was founded in 2010 and is based in Cham, Switzerland. As of October 7, 2020, Bionovate Technologies Corp. operates as a subsidiary of Human Data AG.
Bionovate Technologies Corp. is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.
Score
Price History & Performance
Review Bionovate Technologies Corp. in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.
Recent News
Bionovate Technologies Corp. Competitors
Bionovate Technologies Corp. operates in the Medical Devices industry within the Healthcare sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.
Earnings Per Share
EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.
Continue the analysis
Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.
View plans